Placenta Derived Mesenchymal Stem Cells in Combination with Polycaprolactone-20% Tricalcium Phosphate Scaffolds for the Treatment of Critical-Sized Defects of the Mandible
의약학 > 의공학
( Eui Seok Lee ) , ( Byoung Moo Seo ) , ( Jae Suk Rim ) , ( Hyon Seok Jang ) , ( Jong Jin Kwon )
조직공학과 재생의학 2010년, 제7권 제3호, 276~282페이지(총7페이지)
2a800541.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    135원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    Objectives: Polycaprolactone-20% tricalcium phosphate (PCL-TCP) polymers allow for cellular adherence and differentiation and are adequate scaffolds for bone regeneration in tissue engineering strategies. The placenta contains multipotent stem cells. This study evaluated the utility of placenta derived mesenchymal stem cells (PDMSCs) seeded onto PCL-TCP scaffolds for bone tissue engineering. Materials and Methods: PDMSCs were isolated from placenta. PCL-TCP scaffolds with PDMSCs were implanted in full-thickness mandibular bone defects (2×2 cm) in minipigs. In the first experimental group, defects were treated with amnion-derived MSCs placed onto the scaffold, whereas in the second experimental group, defects were treated with deciduas-derived MSCs placed onto the scaffold. As a control, a third defect was treated with the scaffold only. Histological and radiographic examinations were performed twelve weeks post-implantation. Results: Soft radiographic measurements showed that experimental groups had twice the bone density of control group. Experimental groups had a statistically significant increased bone regeneration potential compared to control group in mandibular bone defects in minipigs. Micro CT showed that experimental groups had higher levels of percent of regenerated volume fraction, regenerated bone volumes and regenerated bone surface than control group. The histologic examination revealed the presence of regenerated bone at the central area of defect. Conclusion: PDMSCs seeded into the PCL-TCP scaffolds enhance bone regeneration in mandibular defects. Therefore PCL-TCP scaffold with placenta derived mesenchymal stem cels can increase bone regeneration.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일
    copyright (c) 2009 happynlife. steel All reserved.